315228-30-9Relevant articles and documents
BIS-ARYL ETHERS CONTAINING N-ACYL AZETIDINE AS EGFR/HER2 INHIBITORS
-
Paragraph 120-121, (2021/11/20)
The invention provides compounds and pharmaceutical compositions thereof, which are useful for inhibiting EGFR and erbB2 activity, as well as methods for using such compounds to treat cancer associated with mutant EGFR and erbB2 activity.
Therapeutic modulation of PPARgamma activity
-
Page/Page column 66-67, (2010/02/14)
Modulators of PPARγ activity are used in methods of treating and/or preventing conditions such as osteoporosis, Alzheimer's disease, psoriasis and acne, and cancer.